Jim Cramer asks, why pay any attention to letters from a manager who lost money in the first quarter?
VIDEO ON MSN MONEY
New models from Ford and GM won't affect investors' views. The market cares only about sales.
We got news of new cars galore Monday. We heared about midsize cars from the Big Three that could challenge the Japanese, cars with technology that appeals to youths, cars that show off U.S. craftsmanship in a way that makes the Japanese seem, well, equal to -- not better than -- Ford (F), GM (GM) or Chrysler.
If only it mattered to the stocks. First, we don't care about Chrysler unless we are trying to buy one. The idea of buying a European car company because of a strong Chrysler showing is pretty fanciful. Fiat is good. So what?
Even after a huge rally in 2011, this stock still has a full tank of gas.
By Nathan Slaughter, Energy & Income
Golar LNG (GLNG) shareholders will have fond memories of 2011 -- the stock delivered an impressive 196% return for the year. But the rally isn't over yet, because the same tailwinds behind it will continue blowing through at least 2014.
These stocks are in the sweet spot for continuing their winning ways into this year and beyond.
By Richard Moroney, Upside
Special to MoneyShow.com
Cascade (CASC): The leading maker of material handling equipment in North America, this company is highly leveraged to demand for forklifts. Its primary end markets include pulp and paper, grocery products, textiles, and consumer goods. Cascade has rallied 12% since announcing impressive October quarter results on Dec. 1.
Per-share earnings were $1.74, up from 79 cents and handily above the consensus of $1.20. Results reflect lower interest expense, a favorable tax rate, and improved gross profit margins. Total revenue increased 29% to $138 million and beat the consensus by $5 million. Sales have topped expectations in five of the last six quarters.
The payoff for CEO Reed Hastings' international push may take a long time.
For example, business leaders in the U.K. expect the country's economy to get worse in 2012, according to a poll released Monday. A recent Goldman Sachs survey forecast that the U.K.'s gross domestic product (GDP) will rise 0.7% this year, down from 0.9% in 2011.
The retailer sends mixed signals regarding the future of the e-reader.
What on earth is Barnes & Noble (BKS) doing pondering the spin-off of the division that makes its Nook e-readers and tablets? It’s hard to find a way to "spin" that news into anything resembling an upbeat signal for either Barnes & Noble or its stock.
William Lynch, the bookseller’s CEO, dropped the possibility of a spin-off into a discussion of the company’s prospects last week, even as he revealed that year-end results are likely to fall short of investors’ hopes and analysts’ forecasts.
Pipelines and processing plants put this MLP in the sweet spot as US gas production ramps up.
By Amy Calistri, The Daily Paycheck
Enterprise Products Partners LP (EPD), a Houston-based master limited partnership (MLP), operates over 50,000 miles of gas, crude oil, natural gas liquids (NGL) and petrochemical pipelines.
Travelers is upgraded to 'conviction buy' at Goldman, while Akamai is downgraded to 'sell' at Citigroup.
Monday's noteworthy upgrades include:
- Broadcom (BRCM) upgraded to Buy from Hold at Deutsche Bank
- Comcast (CMCSA) upgraded to Outperform from Neutral at Macquarie
- Hartford Financial (HIG) upgraded to Buy from Neutral at Goldman
- MetLife (MET) upgraded to Buy from Neutral at Goldman
- Travelers (TRV) upgraded to Conviction Buy from Buy at Goldman
- Akamai (AKAM) upgraded to Hold from Underperform at Jefferies
- J.C. Penney (JCP) upgraded to Hold from Sell at Deutsche Bank
The company's generics business is poised to grow after it recorded revenue of nearly $10 billion in 2010.
Biopharmaceutical includes primary care, specialty care, established products, emerging markets and oncology units that focus on treatment and prevention of cardiovascular and metabolic diseases, central nervous system disorders, arthritis and pain, respiratory diseases, urogenital conditions, cancer, eye disease and endocrine disorders, among others. Its diversified unit includes animal health, consumer health and nutritional products such as nutritional supplements and toddler formula products.
Booming foreign interest in domestic reserves creates big opportunity.
The U.S. and Canada are sitting on one of the biggest energy booms ever. An oil and gas production renaissance is under way, thanks to improved hydraulic fracturing and advances in drilling techniques. Though not without controversy, shale formations like the Marcellus, Utica and Eagle Ford have become hotbeds of North American drilling activity because these advances have made it possible to extract the plethora of fossil fuels trapped between the rocks.
With billions of dollars in revenue at stake, these regions have witnessed a land grab not seen since the California Gold Rush of the 1800s. While the usual suspects like Exxon (XOM) are staking their claims, North America's shale interests are getting plenty of attention from overseas sources as well.
Positive action on new drugs by FDA in 2011 bodes well for biopharmaceuticals in 2012, and Celgene can offer long-term growth.
"We see the FDA's modestly raised fiscal 2012 budget supporting continued improvement in the approval of new drugs on first review cycle," says Steven Silver, a biotech analyst at Standard & Poor's. The FDA's approval of new drugs in 2011 jumped 63% after an increase of about 50% in 2010, indicating a much-improved dedication by the FDA in supporting biotech and pharmaceutical companies in their quest for badly needed new drugs, Silver argues.
A recently launched oil and gas trust offers protected payouts and attractive yield.
By Elliott Gue, The Energy Strategist
Chesapeake Granite Wash Trust (CHKR), the newest addition to the universe of U.S. oil and gas trusts, went public on Nov. 11. It is also among the most promising and fastest-growing trusts in my coverage universe.
Diversified holdings in utilities, commodities and transportation sectors offer stable cash flow.
By Gordon Pape, The Canada Report
This will be a year of uncertainty. Since I am a conservative investor by nature, I am selecting a security with limited downside risk, stable assets and good cash flow.
The year has started off well, but some sectors and strategies have the potential to pay off even better in coming weeks.
By Tom Aspray, MoneyShow.com
The first week of the New Year has certainly been a good one for the stock market, as the S&P 500 finished the week up 1.3% and the Dow Industrials gained 1.1%. This was in contrast to the 3.4% gain in the Nasdaq-100.
There was little in the way of bad news from the eurozone (for a change), though yields on many of the euro bonds are still at dangerously high levels. Upcoming bond auctions in euro land will be watched closely.
Major oil producers saw output reduced because of the natural decline in production fields, asset sales and political issues.
Brent prices remained above the $100 per barrel mark for most of the year, driven by an improved economic outlook in the first half of the year and supply concerns in the second half. The year also saw the announcement that ConocoPhillips (COP) would divest its downstream business and focus on upstream exploration and production and unconventional resources such as shale.
Gold miner has production volume, growth projects and seasonal factors in its favor.
By Curtis Hesler, The Professional Timing Service
There was a study done in the 1970’s that revealed that gold stocks tended to bottom in the fourth quarter and rally strongly into the end of the first quarter of the next year. Thus, looking for seasonal bargains in the gold sector makes sense, especially now.
MORE ON MSN MONEY
Copyright © 2014 Microsoft. All rights reserved.
The new restaurant, the first of which will open this summer, features premium tacos, fries, craft beer and wine.
Top Stocks provides analysis about the most noteworthy stocks in the market each day, combining some of the best content from around the MSN Money site and the rest of the Web.
Contributors include professional investors and journalists affiliated with MSN Money.
Follow us on Twitter @topstocksmsn.
[BRIEFING.COM] The Nasdaq Composite (+0.5%) and S&P 500 (+0.2%) posted modest gains on Thursday, but not before enduring a morning dip into the red, which took place in reaction to reports indicating Russia has commenced military exercises on the Ukrainian border.
The news from Europe knocked the key indices from their early highs, while giving a boost to safe-haven assets like gold futures (+0.5% to $1290.80/ozt), Treasuries (10-yr yield -1 bps to 2.69%), and the Japanese yen (102.30 ... More
More Market News
|There’s a problem getting this information right now. Please try again later.|